Target intelligence / Profile preview

Mucus network

Molecular classification
Glycoprotein network, Biological hydrogel, Extracellular matrix-like structure
01

Overview

The mucus network is a complex, three-dimensional hydrogel that lines the epithelial surfaces of the respiratory, gastrointestinal, and urogenital tracts. It is primarily composed of large, heavily glycosylated proteins known as mucins, such as MUC5AC and MUC5B in the airways and MUC2 in the intestines, which cross-link via disulfide bonds to form a protective mesh [1.1.4, 1.3.1]. This network serves as a critical biological barrier, providing lubrication, maintaining surface hydration, and selectively filtering pathogens and toxins while allowing the exchange of nutrients and gases [1.3.2, 1.3.5]. In pathological conditions like cystic fibrosis, COPD, and asthma, the network becomes hyper-viscous and stagnant due to mucin overproduction, dehydration, or the accumulation of extracellular DNA from inflammatory cells [1.1.2, 1.2.5]. Therapeutic interventions target the physical properties of this network to restore clearance, using mucolytics to break chemical cross-links, DNases to degrade structural DNA, or osmotic agents to increase hydration [1.2.5, 1.4.1]. Understanding the rheological and biochemical properties of the mucus network is essential for developing effective transmucosal drug delivery systems and treating chronic obstructive airway diseases [1.3.3, 1.4.2].

Other names
Mucin networkMucus barrierMucus gelAirway mucusIntestinal mucus barrierMucosal barrier
02

Mechanism of action

Disruption of disulfide bonds in mucin polymers, hydrolysis of extracellular DNA, osmotic hydration of the mucus gel, and stimulation of mucociliary clearance.

03

Biological functions

ProtectionLubricationSelective permeability barrierMucociliary clearanceHydrationMicrobiota hosting
04

Disease associations

Cystic fibrosisChronic obstructive pulmonary disease (COPD)AsthmaInflammatory bowel disease (IBD)Gastric ulcerBronchitis
05

Safety considerations

BronchospasmAirway irritationDisruption of protective barrier functionCoughNausea
06

Interacting drugs

N-acetylcysteine

8 more in the full profile.

07

Biomarkers

Sputum viscosityMUC5AC/MUC5B ratioSputum DNA concentrationMucociliary clearance rateMucin concentration

Beyond the preview

Go deeper on Mucus network.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucus network.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call